RT Journal Article
SR Electronic
T1 Multiscale predictability of Cutaneous Leishmaniasis in Morocco and Tunisia through the AMO-NAO coupling and its modulation of regional rainfall
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.12.14.23299949
DO 10.1101/2023.12.14.23299949
A1 San-José, Adrià
A1 Aoun, Karim
A1 Lemrani, Meryem
A1 Idis, Mhaidi
A1 Bouratbine, Aida
A1 Paul, Richard
A1 Rodó, Xavier
YR 2024
UL http://medrxiv.org/content/early/2024/01/17/2023.12.14.23299949.abstract
AB The development of effective Early Warning Systems (EWS) for climate-driven zoonotic diseases has been hindered by a lack of predictors with adequate lead time for effective interventions. Atmosphere-Ocean coupled phenomena present predictability beyond the atmospheric deterministic limits and therefore are potentially useful climate drivers to be integrated in mathematical models. While the El Niño-Southern Oscillation (ENSO) has been used to forecast disease dynamics in equatorial and tropical regions, there is a lack of similar applications for temperate areas, likely because of the perceived unpredictability of atmospheric systems such as the North Atlantic Oscillation (NAO). This study challenges this notion by establishing a connection between the NAO and its oceanic counterpart, the Atlantic Multidecadal Oscillation (AMO), revealing common low-frequency components that strongly modulate Cutaneous Leishmaniasis (CL) in Northern Africa. We demonstrate not only short-term couplings, such as the known NAO’s impact on seasonal rainfall, which subsequently affects CL incidence, but we also uncover a significant lagged effect of approximately three years on rainfall and four years on CL incidence. Our findings reveal a unified, multiscale mechanism that influences CL epidemiology across different time scales, underscoring the predictive skill for short and long term time frames, which should be integrated in CL forecasting models.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon request to the authors